Wei Gan

Zhongshan, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 57 publications

RASA2 Promotes Pancreatic Cancer Metastasis by Activating TGFβ-Dependent Non-canonical Hedgehog Signaling.

RASA2 Promotes Pancreatic Cancer Metastasis by Activating TGFβ-Dependent Non-canonical Hedgehog Signaling.

Journal: Cancer research

Published: January 22, 2026

Clinicopathological and molecular determinants of pancreatic neuroendocrine tumors: toward precision risk stratification.

Clinicopathological and molecular determinants of pancreatic neuroendocrine tumors: toward precision risk stratification.

Journal: Journal of translational medicine

Published: January 14, 2026

Pathomics Signature for Prognosis and CA19-9 Interception in Pancreatic Ductal Adenocarcinoma: A Real-Life, Multi-Center Study.

Pathomics Signature for Prognosis and CA19-9 Interception in Pancreatic Ductal Adenocarcinoma: A Real-Life, Multi-Center Study.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: August 19, 2025

Clinical subtypes of stage IV pancreatic ductal adenocarcinoma: a new perspective of clinical practices.

Clinical subtypes of stage IV pancreatic ductal adenocarcinoma: a new perspective of clinical practices.

Journal: Cancer metastasis reviews

Published: May 30, 2025

Impact of external drainage of the main pancreatic duct and common bile duct on postoperative pancreatic fistula following pancreatoduodenectomy: protocol for a multicentre randomized clinical trial.

Impact of external drainage of the main pancreatic duct and common bile duct on postoperative pancreatic fistula following pancreatoduodenectomy: protocol for a multicentre randomized clinical trial.

Journal: BJS open

Published: March 03, 2025

Emergence profiles of remimazolam-flumazenil versus propofol in pediatric general anesthesia for strabismus correction: a randomized clinical trial.

Emergence profiles of remimazolam-flumazenil versus propofol in pediatric general anesthesia for strabismus correction: a randomized clinical trial.

Journal: BMC anesthesiology

Published: February 06, 2025

The Crosstalk with CXCL10-Rich Tumor-Associated Mast Cells Fuels Pancreatic Cancer Progression and Immune Escape.

The Crosstalk with CXCL10-Rich Tumor-Associated Mast Cells Fuels Pancreatic Cancer Progression and Immune Escape.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: December 29, 2024

Intratumoral IL-33 + CD4 + FoxP3 + regulatory T cell infiltration determines poor clinical outcomes and intensive immunoevasive contexture in patients with pancreatic cancer after surgical resection: a cohort study.

Intratumoral IL-33 + CD4 + FoxP3 + regulatory T cell infiltration determines poor clinical outcomes and intensive immunoevasive contexture in patients with pancreatic cancer after surgical resection: a cohort study.

Journal: International journal of surgery (London, England)

Published: November 27, 2024

Exploring the ED50 and ED95 of Remimazolam for Laryngeal Mask Airway Insertion During General Anesthesia in Pediatric Strabismus Correction Surgery.

Exploring the ED50 and ED95 of Remimazolam for Laryngeal Mask Airway Insertion During General Anesthesia in Pediatric Strabismus Correction Surgery.

Journal: Annali italiani di chirurgia

Published: August 26, 2024

Effectiveness of a BCW-based interactive pictorial health education program among patients with hypertension in the urban-rural fringe area in China.

Effectiveness of a BCW-based interactive pictorial health education program among patients with hypertension in the urban-rural fringe area in China.

Journal: Patient education and counseling

Published: July 18, 2024

Effective Antiviral Therapy Improves Immunosuppressive Activities in the Immune Microenvironment of Hepatocellular Carcinoma by Alleviating Inflammation and Fibrosis.

Effective Antiviral Therapy Improves Immunosuppressive Activities in the Immune Microenvironment of Hepatocellular Carcinoma by Alleviating Inflammation and Fibrosis.

Journal: Cancer medicine

Published: May 15, 2024

Targeting CD73 limits tumor progression and enhances anti-tumor activity of anti-PD-1 therapy in intrahepatic cholangiocarcinoma.

Targeting CD73 limits tumor progression and enhances anti-tumor activity of anti-PD-1 therapy in intrahepatic cholangiocarcinoma.

Journal: Journal of cancer research and clinical oncology

Published: May 10, 2024

Showing 1-12 of 57

Last Updated: 09/26/2026